Advertisement

Human Humoral Immunity in SCID Mice

  • Mohammad R. Abedi
  • Lennart Hammarström
  • Birger Christensson
  • C. I. Edvard Smith
Part of the Medical Intelligence Unit book series (MIU.LANDES)

Abstract

In 1983, Bosma and colleagues discovered an autosomal recessive mutation (scid) in the C.B-17 mouse strain that resulted in marked deficiencies in both humoral and cell-mediated immunities.1 The mutant locus was mapped close to the mahoganoid locus, centromeric to the Ig light chain locus on chromosome 16.2 The mutation appears to impair the recombination of antigen receptor genes. Therefore, mice homozygous for scid (SCID mice) are severely deficient in B and T lymphocytes and are highly susceptible to infections. Subsequently, it was shown that the mutation also affects double-stranded DNA repair in other cells and tissues in SCID mice.3,4 Presumably, the DNA repair enzyme is critical to immunoglobulin (Ig) and T-cell receptor VDJ gene segment rearrangement in lymphocytes56 and its absence leads to the failure of B and T cells to express their antigen receptors, and immune function in SCID mice can be fully restored after reconstitution with normal mouse bone marrow.7 In 1988, two methods for the partial reconstitution of a human immune system in SCID mice were described.8,9 McCune and colleagues developed chimeric SCID-hu mice by IV administration of progenitor cells from human fetal liver to SCID mice that had previously been engrafted with human fetal thymus.8 Mosier et al established the hu-PBL-SCID mouse system by IP transfer of human peripheral blood mononuclear cells (PBL) into SCID mice,9 and Kamel-Reid et al and Lapidot et al utilized human bone marrow in different systems to reconstitute SCID mice.10–12 Such chimeric mice present certain characteristics of the human immune system and are being used as in vivo models of human hematopoiesis, infectious diseases, autoimmunity, and tumorigenesis. The majority of studies on human humoral immune response in SCID mice have been performed in the hu-PBL-SCID mouse model. This chapter describes characteristics of SCID mice reconstituted with human lymphoid cells, mainly hu-PBL-SCID mice, with emphasis on parameters which may be relevant to humoral immunity.

Keywords

Human Peripheral Blood Mononuclear Cell Severe Combine Immunodeficiency Systemic Lupus Erythematous Human Peripheral Blood Lymphocyte Severe Combine Immunodeficient Mouse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527–30.PubMedCrossRefGoogle Scholar
  2. 2.
    Bosma GC, Davisson MT, Ruetsch NR et al. The mouse mutation severe combined immune deficiency (scid) is on chromosome 16:published erratum appears in Immunogenetics 1989; 29(3):224. Immunogenetics 1989; 29: 54–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Fulop GM, Phillips RA. The scid mutation in mice causes a general defect in DNA repair. Nature 1990; 347: 479–82.PubMedCrossRefGoogle Scholar
  4. 4.
    Hendrickson EA, Qin XQ, Bump FA et al. A link between double-strand break-related repair and V(D)J recombination: the scid mutation. Proc Natl Acad Sci U S A 1991; 88: 4061–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Schuler W, Weiler IJ, Schuler A et al. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 1986; 46: 963–72.PubMedCrossRefGoogle Scholar
  6. 6.
    Malynn BA, Blackwell TK, Fulop GM et al. The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 1988; 54: 453–60.PubMedCrossRefGoogle Scholar
  7. 7.
    Dorshkind K, Keller GM, Phillips RA et al. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol 1984; 132: 1804–8.PubMedGoogle Scholar
  8. 8.
    McCune JM, Namikawa R, Kaneshima H et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Mosier DE, Gulizia RJ, Baird SM et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Kamel-Reid S, Letarte M, Sirard C et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989; 246: 1597–600.PubMedCrossRefGoogle Scholar
  11. 11.
    Kamel-Reid S, Letarte M, Doedens M et al. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood 1991; 78: 2973–81.PubMedGoogle Scholar
  12. 12.
    Lapidot T, Pflumio F, Doedens M et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992; 255: 1137–41.PubMedCrossRefGoogle Scholar
  13. 13.
    Murphy WJ, Bennett M, Anver MR et al. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 1992; 22: 1421–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Martino G, Anastasi J, Feng J et al. The fate of human peripheral blood lymphocytes after transplantation into SCID mice. Eur J Immunol 1993; 23: 1023–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Duchosal MA, Eming SA, McConahey PJ et al. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease. Am J Pathol 1992; 141: 1097–113.PubMedGoogle Scholar
  16. 16.
    Hesselton RM, Koup RA, Cromwell MA et al. Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution. J Infect Dis 1993; 168: 630–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Chen C, Nadal D, Cohen SA et al. Direct demonstration of engraftment of human peripheral blood leukocytes in SCID mice. Int Arch Allergy Appl Immunol 1992; 97: 295–300.CrossRefGoogle Scholar
  18. 18.
    Carlsson R, Mârtensson C, Kalliomäki S et al. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies. J Immunol 1992; 148: 1065–71.PubMedGoogle Scholar
  19. 19.
    Hoffmann-Fezer G, Kranz B, Gall C et al. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors. Eur J Immunol 1992; 22: 3161–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Abedi MR, Christensson B, Islam KB et al. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur J Immunol 1992; 22: 823–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Ladel CH, Kaufmann SH, Bamberger U. Localisation of human peripheral blood leukocytes after transfer to C.B-17 seid/seid mice. Immunol Lett 1993; 38: 63–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Saxon A, Macy E, Denis K et al. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest 1991; 87: 658–65.PubMedCrossRefGoogle Scholar
  23. 23.
    Nadal D, Albini B, Chen CY et al. Distribution and engraftment patterns of human tonsillar mononuclear cells and immunoglobulin-secreting cells in mice with severe combined immunodeficiency: role of the Epstein-Barr virus. Int Arch Allergy Appl Immunol 1991; 95: 341–51.PubMedCrossRefGoogle Scholar
  24. 24.
    Tary-Lehmann M, Saxon A. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med 1992; 175: 503–16.PubMedCrossRefGoogle Scholar
  25. 25.
    Kubota T, Yamaguchi H, Watanabe M et al. High human IgG levels in severe combined immunodeficient mouse reconstituted with human splenic tissues from patients with gastric cancer. Jpn J Cancer Res 1992; 83: 300–3.PubMedCrossRefGoogle Scholar
  26. 26.
    Duchosal MA, Eming SA, McConahey PJ et al. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice. Cell Immunol 1992; 139: 468–77.PubMedCrossRefGoogle Scholar
  27. 27.
    Kilchherr E, Mandak V, Wagner K et al. Regulation of human IgE response in hu-PBL-SCID mice. Cell Immunol 1993; 151: 241–56.PubMedCrossRefGoogle Scholar
  28. 28.
    Smith CIE, Abedi MR, Islam KB et al. Humoral immunity in seid mice reconstituted with cells from immunoglobulin-deficient or normal humans. Immunol Rev 1991; 124: 113–38.PubMedCrossRefGoogle Scholar
  29. 29.
    Hassan MS, Abedi-Valugerdi M, Lefranc G et al. Biological half-life of normal and truncated human IgG3 in seid mice. Eur J Immunol 1991; 21: 1319–22.PubMedCrossRefGoogle Scholar
  30. 30.
    Zuckier LS, Georgescu L, Chang CJ et al. The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G. Cancer 1994; 73: 794–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Waldman TA, Strober W. Metabolism of immunoglobulins. Prog Allergy 1969; 13: 1–110.Google Scholar
  32. Mestecky J, McGhee JR. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987; 40:153–245.Google Scholar
  33. 33.
    Jackson GDF, Lemaitre-Coelho I, Vaerman JP et al. Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. Eur J Immunol 1978; 8: 123–126.PubMedCrossRefGoogle Scholar
  34. 34.
    Orlans E, Peppard J, Reynolds J et al. Rapid active transport of immunoglobulin A from blood to bile. J Exp Med 1978; 147: 588–592.PubMedCrossRefGoogle Scholar
  35. 35.
    Lue C, Kiyono H, Fujihashi K et al. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens. Reg Immunol 1992; 4: 86–90.PubMedGoogle Scholar
  36. 36.
    Aaberge IS, Michaelsen TE, Rolstad AK et al. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect Immun 1992; 60: 4146–53.PubMedGoogle Scholar
  37. 37.
    Ueno Y, Ichihara T, Hasui M et al. T-cell-dependent production of IgG by human cord blood B cells in reconstituted SCID mice. Scand J Immunol 1992; 35: 415–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Spiegelberg HL, Beck L, Kocher HP et al. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice. J Clin Invest 1994; 93: 711–7.CrossRefGoogle Scholar
  39. 39.
    Cavacini LA, Kennel M, Lally EV et al. Human immunoglobulin production in immunodeficient mice: enhancement by immunosuppression of host and in vitro activation of human mononuclear cells. Clin Exp Immunol 1992; 90: 135–40.PubMedCrossRefGoogle Scholar
  40. 40.
    Macht LM, Leader KA, Corrall RJ et al. Failure of blood mononuclear cells from human donors with autoimmune haemolytic anaemia to reconstitute severe combined immunodeficient mice. Autoimmunity 1992; 14: 127–35.PubMedCrossRefGoogle Scholar
  41. 41.
    Hasui M, Miyawaki T, Ichihara T et al. Mature helper T cell requirement for immunoglobulin production by neonatal native B cells injected intraperitoneally into severe combined immunodeficient (SCID) mice. Clin Exp Immunol 1994; 95: 357–61.PubMedCrossRefGoogle Scholar
  42. 42.
    Mosier DE, Picchio GR, Baird SM et al. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes. Cancer Res 1992; 52 (Suppl.): 5552s - 3s.PubMedGoogle Scholar
  43. 43.
    Cannon MJ, Pisa P, Fox RI et al. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 1990; 85: 1333–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Okano M, Taguchi Y, Nakamine H et al. Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. Am J Pathol 1990; 137: 517–22.PubMedGoogle Scholar
  45. 45.
    Durandy A, Brousse N, Rozenberg F et al. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest 1992; 90: 945–52.PubMedCrossRefGoogle Scholar
  46. 46.
    Ghetie MA, Richardson J, Tucker T et al. Antitumor activity of Fab’ and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites. Cancer Res 1991; 51: 5876–80.PubMedGoogle Scholar
  47. 47.
    Ghetie MA, Tucker K, Richardson J et al. The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin. Blood 1992; 80: 2315–20.PubMedGoogle Scholar
  48. 48.
    Ghetie MA, Picker LJ, Richardson JA et al. Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest. Blood 1994; 83: 1329–36.PubMedGoogle Scholar
  49. 49.
    Hersh EM, Grogan TM, Funk CY et al. Suppression of human lymphoma development in the severe combined immune-deficient mouse by imexon therapy. J Immunother 1993; 13: 77–83.CrossRefGoogle Scholar
  50. 50.
    Abedi MR, Christensson B, al-Masud S et al. Gamma-globulin modulates growth of EBV-derived B-cell tumors in SCID mice reconstituted with human lymphocytes. Int J Cancer 1993; 55: 824–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Kumpel BM, Poole GD, Jackson DJ. Specific anti-responses of SCID mice populated with human lymphoid cells from peripheral blood, umbilical cord, bone marrow and spleen after immunization with group A erythrocytes. Immunol Lett 1992; 33: 163–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Pflumio F, Lapidot T, Murdoch B et al. Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol 1993; 5: 1509–22.PubMedCrossRefGoogle Scholar
  53. 53.
    Kusakari C, Takasaka T. Reconstitution of immunological imbalance in SCID mice given tonsillar mononuclear cells from patients with IgA nephropathy. Acta Otolaryngol Suppl 1993; 508: 19–22.PubMedCrossRefGoogle Scholar
  54. 54.
    Vandekerckhove BA, Jones D, Punnonen J et al. Human Ig production and isotype switching in severe combined immunodeficient-human mice. J Immunol 1993; 151: 128–37.PubMedGoogle Scholar
  55. 55.
    Leader KA, Macht LM, Steers F et al. Antibody responses to the blood group antigen D in SCID mice reconstituted with human blood mononuclear cells. Immunology 1992; 76: 229–34.PubMedGoogle Scholar
  56. 56.
    Bitoh S, Lang GM, Kierek-Jaszczuk D et al. Specific immunosuppression of human anti-murine antibody responses in hu-PBL-SCID mice. Hum Antibodies Hybridomas 1993; 4: 134–43.PubMedGoogle Scholar
  57. 57.
    Nadal D, Albini B, Schläpfer E et al. Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol 1991; 85: 358–64.PubMedCrossRefGoogle Scholar
  58. 58.
    Duchosal MA, Eming SA, Fischer P et al. Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature 1992; 355: 258–62.PubMedCrossRefGoogle Scholar
  59. 59.
    Shpitz B, Chambers CA, Singhal AB et al. High level functional engraft-ment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods 1994; 169: 1–15.PubMedCrossRefGoogle Scholar
  60. 60.
    Purtilo DT, Falk K, Pirruccello SJ et al. SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humans. Int J Cancer 1991; 47: 510–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Pirruccello SJ, Nakamine H, Beisel KW et al. Hemagglutination and graftversus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model. Am J Pathol 1992; 140: 1187–94.PubMedGoogle Scholar
  62. 62.
    Williams SS, Umemoto T, Kida H et al. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies. J Immunol 1992; 149: 2830–6.PubMedGoogle Scholar
  63. 63.
    Neil GA, Sammons DW. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion. Hum Antibodies Hybridomas 1992; 3: 201–5.PubMedGoogle Scholar
  64. 64.
    Lucas AH, Siff TE, Trujillo KH et al. Vaccine-induced human antibody responses to the Haemophilus influenzae b polysaccharide in severe combined immunodeficient mice engrafted with human leukocytes. Pediatr Res 1992; 32: 132–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Markham RB, Donnenberg AD. Effect of donor and recipient immunization protocols on primary and secondary human antibody responses in SCID mice reconstituted with human peripheral blood mononuclear cells. Infect Immun 1992; 60: 2305–8.PubMedGoogle Scholar
  66. 66.
    Mazingue C, Cottrez F, Auriault C et al. Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells. Eur J Immunol 1991; 21: 1763–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Sandhu J, Shpitz B, Gallinger S et al. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol 1994; 152: 3806–13.PubMedGoogle Scholar
  68. 68.
    Niguma T, DeVito LD, Grailer AP et al. Activation of HLA-A2-specific memory B cells in severe combined immunodeficient mice. Hum Immunol 1993; 37: 7–16.PubMedCrossRefGoogle Scholar
  69. 69.
    Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361: 226–233.PubMedCrossRefGoogle Scholar
  70. 70.
    Simpson E, Farrant J, Chandler P. Phenotypic and functional studies of human peripheral blood lymphocytes engrafted in scid mice. Immunol Rev 1991; 124: 97–111.PubMedCrossRefGoogle Scholar
  71. 71.
    Smith CIE, Hammarström L. Cellular basis of immunodeficiency. Ann Clin Res 1987; 19: 220–229.PubMedGoogle Scholar
  72. 72.
    Zielen S, Bauscher P, Hofmann D et al. Interleukin 10 and immune restoration in common variable immunodeficiency. Lancet 1993; 342: 750–51.PubMedCrossRefGoogle Scholar
  73. 73.
    Brière F, Bridon JM, Chevet D et al. Interleukin 10 induces B lymphocytes from IgA deficient patients to secrete IgA. J Clin Invest (in press).Google Scholar
  74. 74.
    Krams SM, Dorshkind K, Gershwin ME. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 1989; 170: 1919–30.PubMedCrossRefGoogle Scholar
  75. 75.
    Duchosal MA, McConahey PJ, Robinson CA et al. Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med 1990; 172: 985–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Ashany D, Hines J, Gharavi A et al. Analysis of autoantibody production in SCID-systemic lupus erythematosus (SLE) chimeras. Clin Exp Immunol 1992; 88: 84–90.PubMedCrossRefGoogle Scholar
  77. 77.
    Tighe H, Silverman GJ, Kozin F et al. Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol 1990; 20: 1843–8.PubMedCrossRefGoogle Scholar
  78. 78.
    Fox RI, Pisa P, Pisa EK et al. Lymphoproliferative disease in SCID mice reconstituted with human Sjögren’s syndrome lymphocytes. J Clin Lab Anal 1993; 7: 46–56.PubMedCrossRefGoogle Scholar
  79. 79.
    Davies TF, Kimura H, Fong P et al. The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion. Clin Immunol Immunopathol 1991; 60: 319–30.PubMedCrossRefGoogle Scholar
  80. 80.
    Macht L, Fukuma N, Leader K et al. Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol 1991; 84: 34–42.PubMedCrossRefGoogle Scholar
  81. 81.
    Macht LM, Corrall RJ, Banga JP et al. Control of human thyroid autoantibody production in SCID mice. Clin Exp Immunol 1993; 91: 390–6.PubMedCrossRefGoogle Scholar
  82. 82.
    Martin A, Kimura H, Thung S et al. Characteristics of long-term human thyroid peroxidase autoantibody secretion in scid mice transplanted with lymphocytes from patients with autoimmune thyroiditis. Int Arch Allergy Immunol 1992; 98: 317–23.PubMedCrossRefGoogle Scholar
  83. 83.
    Akasu F, Morita T, Resetkova E et al. Reconstitution of severe combined immunodeficient mice with intrathyroidal lymphocytes of thyroid xenografts from patients with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 1993; 76: 223–30.PubMedCrossRefGoogle Scholar
  84. 84.
    Morita T, Yoshikawa N, Akasu F et al. Studies of thyroid xenografts from Graves’ disease in severe combined immunodeficient mice. J Clin Endocrinol Metab 1993; 77: 255–61.PubMedCrossRefGoogle Scholar
  85. 85.
    Yoshikawa N, Arreaza G, Morita T et al. Effect of removing human Graves’ thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice. J Clin Endocrinol Metab 1994; 78: 367–74.PubMedCrossRefGoogle Scholar
  86. 86.
    Schönbeck S, Padberg F, Hohlfeld R et al. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis. J Clin Invest 1992; 90: 245–50.PubMedCrossRefGoogle Scholar
  87. 87.
    Martino G, DuPont BL, Wollmann RL et al. The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis. Ann Neurol 1993; 34: 48–56.PubMedCrossRefGoogle Scholar
  88. 88.
    Petersen JS, Marshall MO, Baekkeskov S et al. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Diabetologia 1993; 36: 510–5.PubMedCrossRefGoogle Scholar
  89. 89.
    Yates P, Macht LM, Williams NA et al. Red cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anaemia. Br J Haematol 1992; 82: 753–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Feo-Zuppardi FJ, Taylor CW, Iwato K et al. Long-term engraftment of fresh human myeloma cells in SCID mice. Blood 1992; 80: 2843–50.PubMedGoogle Scholar
  91. 91.
    Niguma T, DeVito LD, Grailer AP et al. HLA-A2-specific antibody production in severe combined immunodeficient mice reconstituted with human peripheral blood leukocytes from HLA-presensitized donors. Transplant Proc 1993; 25: 239–40.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Mohammad R. Abedi
  • Lennart Hammarström
  • Birger Christensson
  • C. I. Edvard Smith

There are no affiliations available

Personalised recommendations